{"id":645793,"date":"2023-04-06T14:26:01","date_gmt":"2023-04-06T14:26:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=645793"},"modified":"2023-04-06T14:26:01","modified_gmt":"2023-04-06T14:26:01","slug":"down-syndrome-market-is-predicted-to-exhibit-remarkable-growth-during-the-forecast-period-20222032-analyzes-delveinsight-key-companies-ac-immune-annovis-bio-alzheon-opko-health-inc-aelis","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/down-syndrome-market-is-predicted-to-exhibit-remarkable-growth-during-the-forecast-period-20222032-analyzes-delveinsight-key-companies-ac-immune-annovis-bio-alzheon-opko-health-inc-aelis_645793.html","title":{"rendered":"Down Syndrome Market is Predicted to Exhibit Remarkable Growth During the Forecast Period (2022-2032), Analyzes DelveInsight |Key Companies – AC Immune, Annovis Bio, Alzheon, OPKO Health, Inc., Aelis"},"content":{"rendered":"
\n
\"Down<\/a><\/div>\n
\n
DelveInsight Business Research LLP <\/div>\n<\/div>\n<\/div>\n
DelveInsight’s “Down Syndrome Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Down Syndrome, historical and forecasted epidemiology as well as the Down Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.<\/div>\n

DelveInsight’s “Down Syndrome Market Insights, Epidemiology, and Market Forecast-2032<\/a>“<\/strong> report delivers an in-depth understanding of the Down Syndrome, historical and forecasted epidemiology as well as the Down Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan. The Down Syndrome market report provides current treatment practices, emerging drugs, Down Syndrome market share of the individual therapies, and current and forecasted Down Syndrome market Size from 2019 to 2032 segmented by seven major markets. The Report also covers current Down Syndrome treatment practice\/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the Down Syndrome market.<\/p>\n

Down Syndrome  Overview<\/strong><\/p>\n

Down syndrome is a condition in which a person has an extra chromosome or an extra piece of a chromosome. This extra copy changes how a baby’s body and brain develop. It can cause both mental and physical challenges during their lifetime. Even though people with Down syndrome might act and look similar, each person has different abilities. Down syndrome is usually not inherited. It happens by chance, as an error when cells are dividing during the early development of the fetus. It is not known for sure why Down syndrome occurs or how many different factors play a role. One factor that increases the risk of having a baby with Down syndrome is the age of the mother. Women age 35 and older are more likely to have a baby with Down syndrome.<\/p>\n

\"\"<\/p>\n

Down Syndrome Epidemiological Insights <\/strong><\/p>\n